Skip to main content
See every side of every news story
Published loading...Updated

Following Reopened National Advertising Division Matter, Willow Health Services Voluntarily ...

New York, NY, July 24, 2026 (GLOBE NEWSWIRE) -- In a BBB National Programs’ National Advertising Division challenge brought by Novo Nordisk Inc., Willow Health Services Inc. voluntarily discontinued certain advertising claims for its compounded semaglutide products.

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

icrowdnewswire.com broke the news on Friday, July 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal